Dr. Jia-ling Chou MD

Recommended Articles

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• Living with Lymphoma Day by Day

  A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...

• Lymphoma News: Mother Gives Birth to Healthy Daughter after Chemo During Pregnancy

  Chemotherapy has a reputation for its not-so-great side effects. As many people know, chemotherapy is known to cause off target symptoms for most cancer patients such as nausea and vomiting, hair loss, and extreme fatigue. In addition to the symptoms that one may experience during treatment, some of...

• Stanford University's Linebacker Ryan Beecher Must Now Tackle Lymphoma

  There's no doubt that Ryan Beecher is strong. If you want just watch one Stanford University football game, you'll see that and then some. However, he is now going to have to use a different type of strength in his battle against lymphoma.Ryan's storyWhile many had been following Ryan Beecher before...

• How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma

  Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...